Medicine Information

The P Value And Its Significance


When diversifying an investment portfolio, one needs to consider investing in the healthcare industries. Pharmaceutical companies that have strong pipelines of investigation drugs have strong growth speculations. In addition to examining its pipelines, one also needs to be able to evaluate the results of its clinical trials. When a news program reports the results of a clinical trial for a new drug to be "statistically significant," what does it mean? And how did they come up with that conclusion? One of the most important values to look for when interpreting the results of a study is the P value.

Elenbaas et al defines P value as "the probability that a type I error has been committed, and that the null hypothesis has been falsely rejected." Let's briefly talk about the null hypothesis, type I error, and type II error. Lets say a new drug A is being compared to a currently available drug B. The first assumption that investigators will make is that the new drug A is equivalent or is equal in efficacy to the currently available drug B. This assumption is called the null hypothesis (H0). A contradicting assumption to the null hypothesis is the alternative hypothesis (H1). H1 says that the new drug A is more effective than the currently available drug B. In fact, the alternative hypothesis (H1) is what the investigators want to prove because the pharmaceutical companies developing the new drugs fund most of its clinical trials. Type I error occurs when H0 is rejected when it is really true. In other words, investigators believe that the new drug A is more effective than the currently available drug B (rejecting H0), when drug A is equal in efficacy to drug B, or worst, not as effective as drug B. Type II error occurs when H1 is actually true (drug A is more effective than drug B), but the investigators failed to reject H0 (did not reject the hypothesis that drug A is equal in efficacy as drug B).

With the technical terminologies defined, lets go back to the P value. To reiterate, P value is "the probability that a type I error has been committed, and that the null hypothesis has been falsely rejected." (Elenbass et al). The P value is said to be "statistically significant" when it is < 0.05. For example, a clinical trial comparing the effectiveness between drug A and drug B, found that drug A worked better at lowering the blood pressure than drug B, and the P value was calculated to be 0.04. This means that there is a 4% chance that a type I error is being committed (investigators falsely believe that drug A is more effective than drug B, when they are equal in efficacy). 0.05 is the largest acceptable P value in clinical literature. When investigators claim that drug A is more effective than drug B, they were correct 95% of the time, with only less than 5% chance error.

There are many other important statistical values, but they are beyond the scope of this article. Now, whenever a reporter on television reports the results of a clinical trial for a new drug to be "statistically significant," one can perform their own verification by obtaining a copy of that study and look for the P value.

References:

1. Elenbaas RM, Elenbass JK, and Cuddy PG, et al. Evaluating the medical literature part II: statistical analysis. Annals of Emergency Medicine. October 1983;12(10):35-45.

2. Anderson HG, Kendrach MG, and Trice S, et al. Understanding statistical and clinical significance: hypothesis testing. Journal of pharmacy practice. June 1998;11(3):181-195.

http://www.onlinefreedomwork.com


MORE RESOURCES:
This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news


KTVZ

Four Jefferson Co. youth OD on cold medicine, hospitalized
KTVZ
The Jefferson County District Attorney's Office and Juvenile Department and Madras Police warned parents Tuesday about a spike in juvenile abuse of over-the-counter cold medicines containing dextromethorphan -- which put four youth in the hospital with ...



Forbes

Medicine and Dentistry: Undoing an Illogical 150-Year Divide
Forbes
It's no secret that medicine and dentistry have evolved an unnatural professional separation that is helpful to no one and often causes unnecessary suffering on the part of patients. But we're in a moment—driven by our greater understanding of the ...



Mylan recalls batches of blood pressure medicine in US
Reuters
(Reuters) - Mylan NV said on Tuesday it would recall certain batches of blood pressure medicine valsartan in the United States after they were found to contain a probable cancer-causing impurity, the latest recall amid heightened safety concerns globally.

and more »


Healthcare IT News

Center for Connected Medicine polls top health systems about 2019 ...
Healthcare IT News
The Center for Connected Medicine polled IT executives across 38 health systems for its 2019 Top of Mind survey. Cybersecurity continues to be the biggest ...

and more »


PharmaTimes

Mirati joins CR UK's Stratified Medicine Programme
PharmaTimes
Mirati Therapeutics has joined Cancer Research UK's Stratified Medicine Programme, bringing new investigational treatment options to eligible patients with advanced lung cancer. The partnership will make Mirati's experimental drug, sitravatinib ...



AAFP News (blog)

Bustling Clerkship Shows Family Medicine Is Never Boring
AAFP News (blog)
Not only was family medicine the first specialty I was ever interested in, it was my first third-year clerkship in medical school, too. Although I started medical school thinking family medicine was the specialty for me, it wasn't until my clinical ...



OncLive

Dr. Borgen on Precision Medicine in Breast Cancer
OncLive
The TAILORx trial, which was discussed at the 2018 ASCO Annual Meeting, is a perfect example of precision medicine making its way into this space, according to Borgen. Data from this trial suggested that by applying the precision medicine concept in ...



Elko Daily Free Press

Huynh joins UNR Med Elko Family Medicine Residency Program
Elko Daily Free Press
The Elko Family Medicine Residency Program aims to increase the primary care physician workforce in Elko and the surrounding areas, through the training of resident physicians under the supervision of experienced UNR Med faculty physicians.



News3LV

Pulmonary Medicine
News3LV
Pulmonary Medicine. OptumCare Lung and Allergy Care. Chronic obstructive pulmonary disease, or “COPD” is a chronic inflammatory lung disease that causes obstructed airflow from the lungs. Symptoms include breathing difficulty, cough, mucus production ...

and more »


Flathead Beacon

Zinke to Appeal Ruling in Badger-Two Medicine
Flathead Beacon
Attorneys representing the U.S. Department of the Interior, tribal and environmental groups Tuesday filed a notice of appeal challenging a federal judge's decision to reinstate the last remaining oil and gas leases on the Badger-Two Medicine, an area ...


Google News

home | site map | Dr. Thad Thomas
© 2006